Publications by Kwa, F

Browse Results (21 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Book Chapters (9)
Kwa, F and Karagiannis, T 2012, 'Pathobiology of acute leukaemias' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 9-19. 149  
Kwa, F, Licciardi, P, Rodd, A, Sarila, G, Ververis, K and Karagiannis, T 2012, 'Histone deacetylase inhibitors in the treatment ofhaematological malignancies' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 83-90. 160  
Rodd, A, Kwa, F and Karagiannis, T 2012, 'Pathobiology of cutaneous T-cell lymphoma' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 61-68. 152  
Kwa, F and Karagiannis, T 2012, 'Current therapies for leukaemia' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 47-60. 115  
Licciardi, P, Kwa, F, Di Costanzo, N, Ververis, K and Karagiannis, T 2012, 'Dietary epigenome modifying compounds for the treatment of cancer' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 91-97. 188  
Kwa, F and Karagiannis, T 2012, 'Aetiology and pathogenesis of chronic leukaemias' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 21-29. 262  
Kwa, F and Karagiannis, T 2012, 'Diagnostic and prognostic tools for leukaemia' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 31-45. 203  
Rodd, A, Kwa, F and Karagiannis, T 2012, 'Conventional and novel therapies for cutaneous T-cell lymphoma' in Tom C. Karagiannis and Faith A.A Kwa (ed.) Epigenomic Medicine II - Haematalogical Malignancies, Transworld Research Network, Kerala, India, pp. 69-81. 112  
Kwa, F, Ververis, K, Karagiannis, T and Licciardi, P 2011, 'Emerging epigenetic therapies' in Tom C. Karagiannis (ed.) Epigenomic Medicine, Transworld Research Network, Kerala, India, pp. 93-100. 192  
Journal Articles (12)
Kwa, F, Cole-Sinclair, M and Kapuscinski, K 2019, 'Combination treatment of p53-null HL-60 cells with Histone Deacetylase Inhibitors and Chlorambucil Augments Apoptosis and Increases BCL6 and p21 Gene Expression', Current Molecular Pharmacology, vol. 12, no. 1, pp. 72-81. 7   1 1
Hamadi, A, Grigg, A, Dobie, G, Burbury, K, Schwarer, A, Kwa, F and Jackson, D 2019, 'Ponatinib tyrosine kinase inhibitor induces a thromboinflammatory response', Thrombosis and Haemostasis, vol. 119, no. 7, pp. 1112-1123. 4   1 1
Kwa, F and Jackson, D 2018, 'Manipulating the epigenome for the treatment of disorders with thrombotic complications', Drug Discovery Today, vol. 23, no. 3, pp. 719-726. 10   1 1
Dulull, N, Dias, D, Thrimawithana, T and Kwa, F 2018, 'L-Sulforaphane confers protection against oxidative stress in an in vitro model of age-related macular degeneration', Current Molecular Pharmacology, vol. 11, no. 3, pp. 237-253. 19   3 3
Dulull, N, Thrimawithana, T and Kwa, F 2017, 'Mimicking the ocular environment for the study of inflammatory posterior eye disorders', Drug Discovery Today, vol. 22, no. 2, pp. 440-446. 16   0
Alhawiti, N, Burbury, K, Kwa, F, O'Malley, C, Shuttleworth, P, Grigg, A and Jackson, D 2016, 'The tyrosine kinase inhibitor, nilotinib potentiates a prothombotic state', Thrombosis Research, vol. 145, pp. 54-64. 85   15 Cited 6 times in Scopus6 3
Kwa, F and Thrimawithana, T 2014, 'Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy', Drug Discovery Today, vol. 19, no. 9, pp. 1387-1393. 129   16 0 1
Rafehi, H, Ververis, K, Balcerczyk, A, Ziemann, M, Ooi, J, Hu, S, Kwa, F, Loveridge, S, Georgiadis, G, El-Osta, A and Karagiannis, T 2012, 'Investigation of the biological properties of cinnulin PF in the context of diabetes: mechanistic insights by genome-wide mRNA-Seq analysis', Pathobiology of Aging & Age Related Diseases, vol. 2, pp. 1-14. 176   19
Licciardi, P, Kwa, F, Ververis, K, Di Constanzo, N, Balcerczyk, A, Tang, M, El-Osta, A and Karagiannis, T 2012, 'Influence of natural and synthetic histone deacetylase inhibitors on chromatin', Antioxidants and Redox Signalling, vol. 17, no. 2, pp. 340-354. 48   8 Cited 9 times in Scopus9 0
Kwa, F, Balcerczyk, A, Licciardi, P, El-Osta, A and Karagiannis, T 2011, 'Chromatin modifying agents - the cutting edge of anti-cancer therapy', Drug Discovery Today, vol. 16, no. 1314, pp. 543-547. 139   23 Cited 22 times in Scopus22 0
Kwa, F, Kapuscinski, M and Cole-Sinclair, M 2007, 'Vitamin D Receptor (VDR) Polymorphisms in Chronic Lymphocytic Leukaemia (CLL) Patients (abstract)', Blood (ASH Annual Meeting Abstracts), vol. 110, no. 11, pp. 246B-246B. 255  
Kwa, F, Kapuscinski, M and Cole-Sinclair, M 2007, 'The histone deacetylase inhibitor, sodium butyrate, augments chlorambucil cytotoxicity in the promyelocytic leukaemia cell line, HL-60 (abstract)', Blood (ASH Annual Meeting Abstracts), vol. 110, no. 11, pp. 117B-117B. 129  
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us